Soleno Therapeutics, Inc. (SLNO)
39.90
+0.49
(+1.24%)
USD |
NASDAQ |
Feb 20, 13:41
Soleno Therapeutics EPS Diluted (Quarterly) : 0.4736 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AVITA Medical, Inc. | -0.3825 |
| Assertio Holdings, Inc. | 1.612 |
| Nektar Therapeutics | -1.875 |
| Rigel Pharmaceuticals, Inc. | 1.456 |
| Marker Therapeutics, Inc. | -0.1193 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 26.01M |
| Revenue (Quarterly) | 66.02M |
| Total Expenses (Quarterly) | 40.00M |
| Enterprise Value | 1.670B |
| Gross Profit Margin (Quarterly) | 98.27% |
| Profit Margin (Quarterly) | 39.40% |
| Earnings Yield | -4.62% |
| Normalized Earnings Yield | -4.433 |